Condition: Neurogenic Orthostatic Hypotension · Sponsor: CuraSen Therapeutics, Inc.
This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).
This description comes directly from the study's public registry record.
Chief Medical Officer · 650-475-2842 · info@curasen.com
Medical Monitor · 650-475-2842 · info@curasen.com
Always discuss trial participation with your own doctor first.
| CuraSen Investigational Site | Scottsdale, Arizona, United States | Recruiting |
| CuraSen Investigational Site | Farmington Hills, Michigan, United States | Recruiting |
| CuraSen Investigational Site | Eatontown, New Jersey, United States | Recruiting |
| CuraSen Investigational Site | New York, New York, United States | Recruiting |
| CuraSen Investigational Site | Nashville, Tennessee, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07089043